Davis Polk is advising Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBC Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. as joint lead arrangers and bookrunners in connection with the $130 million amended senior secured credit facilities and the $250 million senior unsecured bridge facility to be provided to an acquisition subsidiary of The Providence Service Corporation to finance, in part, Providence's acquisition of the equity interests of CCHN Group Holdings, Inc.

BDT Capital Partners (“BDT”) has announced in a filing with the United States Securities and Exchange Commission that BDT had raised approximately $5.2 billion of capital commitments from over 100 investors for BDT Capital Partners Fund II, L.P. and its related parallel partnership vehicles. Cravath represented BDT in connection with the fundraising for Fund II.

Advising Aareal Bank AG and PBB Deutsche PfandBriefBank in connection with the senior refinancing of the office tower “Tour First” located in Paris la Défense, held by a Beacon Capital Partners fund, for an amount of 515 million euros and with the negotiation of an additional mezzanine debt with Blackstone for an amount of 60 million euros.

The debt fund Senior European Loan Fund 1, managed by AEW Europe and M&G Investments, are the other financial partners in the context of this transaction.

In a case of first impression, Judge Brodie of the Eastern District of New York granted summary judgment in favor of client U.S. Trust on all of the plaintiff’s claims and struck the plaintiff’s declaration under the “sham affidavit rule.” U.S. Trust managed the plaintiff’s account on a discretionary basis under Reg 9, and also extended several credit facilities to plaintiff, with the discretionary investment account serving as collateral.

Advising Aareal Bank AG in connection with the financing of the acquisition of the office building “32 Blanche” by Oxford Properties Group, the real estate division of Omers, from a real estate fund managed by The Carlyle Group for an amount of approximately 263 million euros.

The Firm represented Goldman Sachs in the initial public offering and Rule 144A/Regulation S offering by Hua Hong Semiconductor Limited. Hua Hong sold an aggregate of 228,696,000 ordinary shares in the offering (before greenshoe) and raised gross proceeds of approximately HK$2,572.8 million (US$332.0 million). The ordinary shares of Hua Hong are listed on the Hong Kong Stock Exchange. Goldman Sachs acted as sole sponsor, sole global coordinator and sole bookrunner.

Schjødt has acted as a legal adviser to Goldman Sachs, ABG Sundal Collier and Swedbank in their capacity as joint global coordinators on the IPO of Entra ASA. In addition to being the first privatization, the IPO is also the largest in the Norwegian market in many years with a market capitalization of NOK 11.9 billion. Entra was prior to the IPO, wholly owned by the Ministry of Trade, Industry and Fisheries.

Noerr has advised Close Brother Seydler Bank AG on two corporate actions of PNE WIND AG, a capital increase with subscription rights and the issue of a convertible bond. Close Brothers was responsible for the structuring and placement of both corporate actions as sole global coordinator and sole bookrunner.

The gross proceeds from both corporate actions are approximately 40 million euros. The funds are to be invested in the endeavoured strategic development of the business model of PNE WIND AG.

Paul Hastings LLP, represented the banks in financing the acquisition of the equity interests and certain oil and gas properties of PDC Mountaineer, LLC by Mountaineer Keystone Energy, LLC.
 
Citigroup Global Markets, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated acted as joint lead arrangers and bookrunners, and Citibank, N.A., acted as administrative agent, on the financing. The financing consisted of a $110 million first lien reserve-based revolving facility.
 

Davis Polk advised Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc. as joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 3,450,000 shares of common stock of PTC Therapeutics, Inc., which included 450,000 shares from the full exercise of the underwriters’ option to purchase additional shares. The common stock is listed on the NASDAQ Global Select Market under the symbol “PTCT."